NCT04249804View on ClinicalTrials.gov

the Use of Magnesium Sulfate for Prevention of Postspinal Shivering

PHASE4CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

January 15, 2020

Primary Completion Date

June 1, 2020

Study Completion Date

June 3, 2020

Conditions
Prevention of Postspinal Shivering
Interventions
DRUG

Magnesium Sulfate 1000 MG

intrathecal versus IV infusion of Magnesium sulfate for prevention of postspinal shivering

Trial Locations (1)

11562

anesthesia department at Cairo University, Cairo

All Listed Sponsors
lead

Cairo University

OTHER

NCT04249804 - the Use of Magnesium Sulfate for Prevention of Postspinal Shivering | Biotech Hunter | Biotech Hunter